Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $2.55 Analyst target: $23.00 Upside: 801.96%
NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company is headquartered in Zurich, Switzerland.
See the full interactive analysis & chart →Informational only — not investment advice.